Evidence map›Paper›PMID 40869313›Full record

ReviewInternational journal of molecular sciences2025

Natural Biomolecules and Light: Antimicrobial Photodynamic Strategies in the Fight Against Antibiotic Resistance.

Greta Amendola, Mariagrazia Di Luca, Antonella Sgarbossa

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Greta AmendolaNational Research Council-Nanoscience Institute (CNR-NANO) and NEST-Scuola Normale Superiore, Piazza S. Silvestro 12, 56127 Pisa, Italy.
Mariagrazia Di LucaDepartment of Biology, University of Pisa, 56127 Pisa, Italy.ORCID 0000-0002-0688-034X
Antonella SgarbossaNational Research Council-Nanoscience Institute (CNR-NANO) and NEST-Scuola Normale Superiore, Piazza S. Silvestro 12, 56127 Pisa, Italy.ORCID 0000-0002-0858-3293

Funding

EU within the NextGenerationEU-MUR PNRR Extended Partnership initiative on Emerging In-fectious Diseases Project no. PE00000007, Spoke5, INF-ACTministry of university, Italy PRIN2020 - 2020LW7XWH
6 · The paper itself

Abstract

The alarming increase in infections caused by antimicrobial-resistant bacteria is increasingly posing a critical threat to public health. For this reason, the scientific community is focusing on alternative therapeutic strategies, such as antimicrobial photodynamic therapy (aPDT). This review examined the use of natural photosensitizers (PSs) in aPDT, emphasizing how they may produce high yields of reactive oxygen species when activated by light and consequently inactivate a wide range of pathogens, including bacteria embedded in biofilms, efficiently. The main methodologies and several strategies of incorporation into cutting-edge nanotechnological delivery systems of the most prevalent natural PSs (curcuminoids, perylenequinones, tetrapyrrolic macrocycles, and flavins) have been analyzed. Although natural PSs have benefits in terms of environmental sustainability and biocompatibility, their clinical use is frequently constrained by low bioavailability and solubility, issues that are being addressed more and more through novel formulations and dual-mode treatments. Studies conducted both in vitro and in vivo highlight these compounds' strong antibacterial and wound-healing properties. In conclusion, natural molecule-based aPDT is a flexible and successful strategy for combating antimicrobial resistance, deserving of more translational study and clinical advancement.

Indexed as

Anti-Bacterial AgentsBiological ProductsDrug Resistance, BacterialDrug Resistance, MicrobialPhotochemotherapyPhotosensitizing AgentsAnimalsBacteriaBacterial InfectionsBiofilmsHumansLightAnti-Bacterial AgentsBiological ProductsPhotosensitizing Agentsantimicrobial photodynamic therapyantimicrobial resistancenatural photosensitizers

Identifiers

PMID40869313
PMCPMC12386932

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.